Susana V. Liwacki
Cordoba, X, Argentina
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications
Efficacy and safety of Cladribine as a therapeutic option in multiple sclerosis patients over 50 years of age: A real-world study.
Journal: Journal of the neurological sciences
Published: August 11, 2025
Progression independent of relapse activity (PIRA) in the Era of high-efficacy treatments.
Journal: Multiple sclerosis and related disorders
Published: June 10, 2025
Determination of disability progression in moderately and highly disabled ambulatory patients with relapsing-remitting multiple sclerosis using the EDSS-Plus: A prospective study in Argentina.
Journal: Multiple sclerosis and related disorders
Published: December 19, 2024
Real-World Effectiveness and Safety of Cladribine in Multiple Sclerosis: Longitudinal Data From the Nationwide Registry in Argentina.
Journal: Clinical neuropharmacology
Published: July 15, 2024
Treatment strategies and responses for attacks of neuromyelitis optica spectrum disorder: A real-world retrospective cohort study.
Journal: Journal of the neurological sciences
Published: May 04, 2024
Traditional first-line treatment failure rates in neuromyelitis optica spectrum disorder patients included in the Argentinean registry (RelevarEM).
Journal: Multiple sclerosis and related disorders
Published: February 26, 2024
Cladribine use trend in Latin America: the changes in patient profile impact in the drug effectiveness.
Journal: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
Published: January 29, 2024
Occurrence of area postrema syndrome during follow-up: phenotype and influence over NMOSD activity in LATAM in real-world settings.
Journal: Journal of neurology
Published: January 20, 2024
Selection of disease modifying therapies in multiple sclerosis based on patient's age and disease activity: Data from a nationwide registry.
Journal: Journal of the neurological sciences
Published: October 22, 2023
Mortality of neuromyelitis optica spectrum disorder patients in an Argentinean population: A study from the RelevarEM registry.
Journal: Multiple sclerosis journal - experimental, translational and clinical
Published: July 05, 2023
Achieving no evidence of disease activity-3 in highly active multiple sclerosis patients treated with cladribine and monoclonal antibodies.
Journal: Multiple sclerosis journal - experimental, translational and clinical
Published: September 27, 2022
Barriers to access and unmet needs to neuromyelitis optica spectrum disorders care in an Argentinean cohort.
Journal: Multiple sclerosis and related disorders
Published: September 26, 2022
Last Updated: 09/26/2026